ArticleSkeletal radiology2026
Accessible cartilage tumor malignancy prediction via vision-language foundation model adaptation.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveTo predict cartilage tumor malignancy from radiographic images combined with readily available non-imaging information based on a vision-language foundation model. MATERIALS AND
methodsThis single-institution study assembled a dataset of 3336 radiographs from 455 patients with enchondroma or chondrosarcoma that was assembled from two sources: (1) patients with histopathology-confirmed diagnoses of enchondroma or chondrosarcoma, and (2) patients with imaging-stable enchondroma without biopsy, confirmed through long-term imaging follow-up. An adapted vision-language foundation model based on the pre-trained CLIP (Contrastive Language-Image Pretraining) architecture was fine-tuned with our proposed Medical Knowledge Adapters and evaluated using 10-fold patient-level cross-validation to predict cartilage tumor malignancy from plain radiographs and demographic information. RESULTS AND
conclusionUsing radiographs alone, the model achieved an Areas Under the receiver operating characteristic Curve (AUC) of 0.91 ± 0.04. Incorporating demographics improved the AUC to 0.94 ± 0.02. Subgroup analysis demonstrated robust generalizability across tumor grades with an AUC of 0.91 ± 0.07 in distinguishing atypical cartilaginous tumors (ACT) previously known as low grade chondrosarcomas, and 0.95 ± 0.02 in differentiating high-grade chondrosarcomas from enchondromas. Within the clinically challenging extremity subgroup (enchondroma vs ACT/LGCS), the model achieved an AUC of 0.79 ± 0.14, reflecting diagnostic difficulty observed in clinical practice. This foundation model-based approach demonstrates strong performance using accessible data sources, offering a non-invasive, cost-efficient, and scalable solution for cartilage tumor assessment in musculoskeletal oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.